Study Design and Case Selection
SECONDARY, THYROID NODULE
The study included patients with a Bethesda III or IV thyroid nodule who underwent an [The trial, including the current secondary analysis, was approved by the Medical Research Ethics Committee on Research Involving Human Subjects region Arnhem-Nijmegen, Nijmegen, the Netherlands. Written informed consent was obtained from each of the participants prior to any study activities.